Insider · CIK 0001526068

Haines Timothy

Reports to the SEC for 3 companies · LONDON, X0

sec.gov

Transactions

Companies

Filings

CIK

0001526068

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-11-12	TARAProtara Therapeutics, Inc.C Conversion	Former Director and 10% Owner	CConversion	+127K sh	$0.99	+$126K	2,144,517
2019-11-12	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Former Director and 10% Owner	CConversion	−126 sh	—	—	2,400
2019-06-14	PROJECT SAGE OLDCO, INC.A Award	Director	AAward	+19.3K sh	—	—	56,982
2018-11-06	PROJECT SAGE OLDCO, INC.S Sale	Director	SSale	−8,514 sh	$21.13	−$180K	2,471,980
2018-11-06	PROJECT SAGE OLDCO, INC.S Sale	Director	SSale	−81.1K sh	$21.60	−$1.75M	2,390,843
2018-06-08	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Former Director and 10% Owner	AAward	+12.7K sh	—	—	12,700
2018-06-05	PROJECT SAGE OLDCO, INC.A Award	Director	AAward	+6,116 sh	$20.44	+$125K	37,662
2018-05-07	PROJECT SAGE OLDCO, INC.P Purchase	Director	PPurchase	+281K sh	$13.50	+$3.8M	2,480,494
2017-06-22	TARAProtara Therapeutics, Inc. · Series A Convertible Preferred StockP Purchase	Former Director and 10% Owner	PPurchase	+2,526 sh	$1000.00	+$2.53M	2,526
2017-06-22	PROJECT SAGE OLDCO, INC.A Award	Director	AAward	+12.9K sh	$9.72	+$125K	31,546
2017-06-20	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Former Director and 10% Owner	AAward	+6,666 sh	—	—	6,666
2016-06-23	PROJECT SAGE OLDCO, INC.A Award	Director	AAward	+18.7K sh	$6.69	+$125K	18,685
2016-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Former Director and 10% Owner	AAward	+6,666 sh	—	—	6,666
2015-06-26	PROJECT SAGE OLDCO, INC.Stock Option (right to buy)A Award	Director	AAward	+7,037 sh	—	—	7,037
2015-06-02	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Former Director and 10% Owner	AAward	+6,666 sh	—	—	6,666
2014-10-29	PROJECT SAGE OLDCO, INC.P Purchase	Director	PPurchase	+495K sh	$15.00	+$7.43M	2,199,012
2014-10-27	TARAProtara Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion	Former Director and 10% Owner	CConversion	−16M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc. · Option (Right to Purchase)J Other	Former Director and 10% Owner	JOther	−12.8M sh	—	—	0
2014-10-27	TARAProtara Therapeutics, Inc.C Conversion	Former Director and 10% Owner	CConversion	+1.07M sh	—	—	2,017,872
2014-10-27	TARAProtara Therapeutics, Inc.P Purchase	Former Director and 10% Owner	PPurchase	+950K sh	$10.00	+$9.5M	950,000
2013-10-11	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2013-10-11	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.5K sh	—	—	0
2013-10-11	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.5K sh	—	—	0
2013-06-13	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2013-06-13	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-06-22	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2012-06-22	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-07-20	Astex Pharmaceuticals, IncDirector Stock Option (Right to buy)A Award	Director	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Nov 144
Haines Timothy0000905718-19-000935
SEC(opens sec.gov)
Jun 184
Haines Timothy0001209191-19-037836
SEC(opens sec.gov)
Nov 84
Haines Timothy0000905718-18-000913
SEC(opens sec.gov)
Jun 114
Haines Timothy0001171843-18-004581
SEC(opens sec.gov)
Jun 74
Haines Timothy0001209191-18-036530
SEC(opens sec.gov)
May 94
Haines Timothy0000905718-18-000470
SEC(opens sec.gov)
Jun 264
PROTEON THERAPEUTICS INC0000905718-17-000624
SEC(opens sec.gov)
Jun 264
Sientra, Inc.0000899243-17-017263
SEC(opens sec.gov)
Jun 214
PROTEON THERAPEUTICS INC0001171843-17-003744
SEC(opens sec.gov)
Jun 274
Sientra, Inc.0001179110-16-026962
SEC(opens sec.gov)
Jun 144
PROTEON THERAPEUTICS INC0001171843-16-010662
SEC(opens sec.gov)
Aug 174
Sientra, Inc.0001179110-15-012245
SEC(opens sec.gov)
Jun 34
PROTEON THERAPEUTICS INC0001104659-15-043089
SEC(opens sec.gov)
Nov 34
Sientra, Inc.0001179110-14-016002
SEC(opens sec.gov)
Oct 294
PROTEON THERAPEUTICS INC0001104659-14-074934
SEC(opens sec.gov)

Companies

Address

C/O ABINGWORTH LLP 38 JERMYN STREET

LONDON, X0, SW1Y 6DN